Turkish Antitrust Authority Approves Tofaş Takeover of Stellantis Distribution Unit

Turkey’s antitrust watchdog has granted conditional approval for Tofaş’s acquisition of Stellantis NV’s local distribution operations, following a revised commitment package that includes promises of investment and support for domestic production.
According to Reuters, the Turkish Competition Board announced on Friday that it had accepted a second round of commitments from the companies, which addressed concerns initially raised earlier this year. The revised proposal includes an investment plan, assurances to safeguard local manufacturing, and detailed steps to enhance distribution and sales infrastructure.
Tofaş, a major automotive manufacturer in Turkey, reached an agreement in 2023 to purchase the entirety of Stellantis Otomotiv’s shares in the country. The deal covers the distribution rights for several major brands, including Peugeot, Citroën, Opel, and DS Automobiles, as reported by Reuters.
Per the board’s statement, Tofaş committed to boosting both production and export capacity, a move expected to significantly impact employment levels in Turkey. The regulator noted that these developments are anticipated to bring long-term benefits to the broader automotive sector.
The initial package of commitments submitted in 2024 was not deemed sufficient by the competition authority, prompting a request for stronger guarantees.
Source: Reuters
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas